Market revenue in 2023 | USD 1,148.9 million |
Market revenue in 2030 | USD 1,556.7 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 17.97% in 2023. Horizon Databook has segmented the U.S. point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Large population at high risk of diabetes in the U.S. is a key factor contributing to the dominance of the U.S. in North America POC glucose testing market in 2020. Diabetes was reported to be 7th most common cause of death in the U.S. with more than 30.9 million Americans suffering from the disease in 2019.
Presence of government organizations focusing on creating awareness regarding diabetes and glucose testing products available in the market has propelled the market growth in the country. For instance, American Heart Association, American Diabetes Association, and Pan American Health Organization are especially involved in such initiatives.
According to International Diabetes Federation, the prevalence rate of diabetes is 13.3% of the total population. Moreover, rising healthcare expenditure on diabetes and increasing cost per person on diabetes are boosting the demand.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account